The emergence of SARS-CoV-2 variants harboring mutations in the spike (S) protein has
raised concern about potential immune escape. Here, we studied humoral and cellular …

The severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant is spreading rapidly, even in vaccinated individuals, raising concerns about immune …

SARS-CoV-2 has been identified as the causative agent of a global outbreak of respiratory
tract disease (COVID-19). In some patients, the infection results in moderate to severe acute …

Background The Ad26.COV2.S vaccine, which was approved as a single-shot immunization
regimen, has been shown to be effective against severe coronavirus disease 2019. …

Containment of the COVID-19 pandemic requires reducing viral transmission. Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is initiated by membrane fusion …

In July 2022, the ongoing monkeypox (MPX) outbreak was declared a public health emergency
of international concern. Modified vaccinia Ankara—Bavarian Nordic (MVA-BN, also …

Influenza vaccination can be less effective in patients treated with immunosuppressive therapy.
However, little is known about the effects of ustekinumab; an anti-IL-12/23 agent used to …

Background The immune response to COVID-19 vaccination is inferior in kidney transplant
recipients (KTRs) and to a lesser extent in patients on dialysis or with chronic kidney disease (…

The ability of SARS-CoV-2 to evolve in response to selective pressures poses a challenge
to vaccine and antiviral efficacy. The S1 subunit of the spike (S) protein contains the receptor-…

Canine distemper virus (CDV) causes systemic infection resulting in severe and often fatal
disease in a large spectrum of animal host species. The virus is closely related to measles …